NCT03900910 Gastric Cancer Prevention for Indigenous Peoples
| NCT ID | NCT03900910 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Gastric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50,000 participants in total. It began in 2018-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The incidence of gastric cancer in local indigenous peoples is higher than the non-Indigenous counterpart in Taiwan. How to design an effective prevention strategy for gastric cancer is of importance. The present study aimed to identify the causes that may account for the health inequalities, allowing generation of a plan of action on the whole population scale.
Eligibility Criteria
Inclusion Criteria: * Aged 20-60 years * Mentally competent to be able to understand the consent form * Able to communicate with study staff for individuals Exclusion Criteria: * Pregnancy * Individuals with major comorbid diseases
Contact & Investigator
Yi-Chia Lee, MD, PhD
PRINCIPAL INVESTIGATOR
National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT03900910 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03900910 currently recruiting?
Yes, NCT03900910 is actively recruiting participants. Contact the research team at yichialee@ntu.edu.tw for enrollment information.
Where is the NCT03900910 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT03900910 clinical trial?
NCT03900910 is sponsored by National Taiwan University Hospital. The principal investigator is Yi-Chia Lee, MD, PhD at National Taiwan University Hospital. The trial plans to enroll 50,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.